News
The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...
Stocktwits on MSN50m
This Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees OpportunityWells Fargo on Thursday raised its price target on Sarepta Therapeutics, Inc. (SRPT) to $50 from $48 after the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback